Funder
Health Resources and Services Administration
Medical College of Wisconsin
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
U.S. Public Health Service
Office of Naval Research
National Institutes of Health
National Cancer Institute
Reference12 articles.
1. Bolon YT AR, Allbee-Johnson M, Estrada-Merly N, Lee SJ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022. accessed 5/14/2024. August 2023 [cited 2024 5/14/2024]; Available from: https://cibmtr.org/CIBMTR/Resources/Summary-Slides-Reports
2. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide;Fuchs;Blood,2022
3. Impact of the HLA immunopeptidome on survival of leukemia patients after unrelated donor transplantation;Crivello;J Clin Oncol,2023
4. CIBMTR. https://cibmtr.org/CIBMTR/Resources/Publicly-Available-Datasets#, (accessed 9/6/2023).
5. The estimation of average hazard ratios by weighted Cox regression;Schemper;Stat Med,2009